Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05810922
Other study ID # F4F- Forest for Future
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 8, 2022
Est. completion date December 22, 2022

Study information

Verified date March 2023
Source Universidade Nova de Lisboa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The tree that produces the arbutus berry, the strawberry tree, scientific name Arbutus unedo L., belongs to the family of Ericaceae. It exists in almost all of Southern Europe in arid and siliceous lands, in woods and forests and is very common in Portugal. Known for its use in the production of liqueurs and brandy, the arbutus berry is a fruit that can be consumed in nature or incorporated in the preparation of other foods. Arbutus berry has been attributed some properties beneficial to health given its low caloric value and its high content of vitamin C and flavonoids, which is why it is considered a good source of antioxidants. Arbutus has a high carbohydrate content (70-80% dry weight) with a relevant fiber fraction (10-30%), constituting an interesting source of vegetable protein (1-9%) and lipids (2-3%). Given this interesting nutritional composition, the hypothesis is that a daily consumption of this fruit can have an impact in health outcomes such as microbiota modulation and an improvement of metabolic parameters.


Description:

The main objective of this clinical trial is to evaluate the effect of including a daily consumption of arbutus berry on the composition and diversity of the intestinal microbiota. It is also intended to evaluate metabolic parameters to determine the impact of this intervention. Participants will consume 50g or 200g of arbutus berry daily for 4 weeks. This study aims to provide scientific evidence regarding the impact of arbutus berry consumption on intestinal microbiota and general health improvements.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 22, 2022
Est. primary completion date December 22, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Caucasian. - Age between 18 and 50 years. - Filling informed consent. - Body mass index (BMI) between 18,5 kg/m2 and 25 kg/m2. Exclusion Criteria: - Arbutus berry sensibility. - Arbutus berry daily consumption in the month before the study begin. - Having taken antibiotics within the 6 months prior to beginning the study. - Use of pro/prebiotics or fiber as a dietary supplement or any food/molecule that modifies intestinal transit time 6 weeks before recruitment. - Use of laxative 6 weeks before recruitment. - Specific nutritional therapy (e.g. high protein). - Excessive alcohol consumption. - Smoking. - Diagnosis of gastrointestinal pathology, hormonal or thyroid pathology, autoimmune diseases, chronic use of corticosteroids, psychiatric disease or Diabetes Mellitus. - Use of proton pump inhibitors, antidiabetic drugs, insulin, or statins. - Pregnant or breastfeeding. - Participation in another clinical trial within the last 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
arbutus berry
consumption of 50 g arbutus berry/day or 200 g arbutus berry/day for 14 days

Locations

Country Name City State
Portugal Nova Medical School Universidade Nova de Lisboa Lisboa

Sponsors (2)

Lead Sponsor Collaborator
Universidade Nova de Lisboa Associação Centro de Apoio Tecnológico Agro-Alimentar de Castelo Branco (CATAA)

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in gut microbiota characterization Difference in gut microbiota taxonomic characterization, from baseline to the end of intervention 14 days
Primary Changes in gut microbiota diversity Difference in gut microbiota Shannon index, from baseline to the end of intervention 14 days
Secondary Changes in fasting glucose Changes in fasting glucose, measured in mg/dL, from baseline to end of intervention 14 days
Secondary Changes in HOMA-IR Changes in HOMA-IR from baseline to end of intervention 14 days
Secondary Changes in HDL cholesterol Changes in HDL from baseline to end of intervention 14 days
Secondary Changes in total cholesterol Changes in total cholesterol, measured in mg/dL, from baseline to end of intervention 14 days
Secondary Changes in LDL cholesterol Changes in LDL cholesterol, measured in mg/dL, from baseline to end of intervention 14 days
Secondary Changes in high sensitivity PCR Changes in high sensitivity PCR, measured in mg/dL, from baseline to end of intervention 14 days
Secondary Changes in IL-6 Changes in IL-6, measured in pg/mL, from baseline to end of intervention 14 days
Secondary Changes in IL-10 Changes in IL-10, measured in pg/mL, from baseline to end of intervention 14 days
Secondary Changes in TNFa Changes in TNFa, measured in pg/mL, from baseline to end of intervention 14 days
Secondary Changes in adiponectin Changes in adiponectin, measured in ng/mL, from baseline to end of intervention 14 days
Secondary Changes in leptin Changes in leptin, measured in ng/mL, from baseline to end of intervention 14 days
Secondary Changes in triglycerides Changes in triglycerides, measured in mg/dL, from baseline to end of intervention 14 days
Secondary Changes in short chain fatty acids amount in the stool Changes in short chain fatty acids in the stool, measured in ng/g fecal sample, from baseline to end of intervention 14 days
Secondary Changes in alkaline phosphatase activity in the stool Changes in alkaline phosphatase activity in the stool, measured in xx/xx, from baseline to end of intervention 14 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Completed NCT04025099 - Internal Cues Versus External Cues for Eating and Activity N/A
Completed NCT04766528 - Effect of Diet on the Microbiota / Endoccanabinoidome Axis in Response to Physical Activity N/A
Completed NCT03277040 - Diet, Eating, and Lifestyle Improvement for Valued Employees and Their Relatives N/A
Active, not recruiting NCT05544461 - Piloting a Web-based Personalised Nutrition App (eNutri) With UK University Students N/A
Active, not recruiting NCT04748835 - The SEEA (SCI Energy Expenditure and Activity) Study
Active, not recruiting NCT04991142 - Models of Nutrition From Continuous Glucose Monitors
Recruiting NCT04487015 - A Digital Approach to Improving Carbohydrate Periodisation Behaviours in Athlete: SMART+ Study N/A
Completed NCT03748056 - Targeted Food Incentives to Improve Diet Quality and Health Among Adults N/A
Not yet recruiting NCT05960396 - Exploring the Mechanism of Dietary Pattern Improving MAFLD N/A
Enrolling by invitation NCT04314882 - The Danish National Survey of Diet and Physical Activity 2021-2023
Terminated NCT04677322 - TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
Completed NCT03855098 - Biomarkers of Food Intake Using a Cross-over Feeding Study N/A
Completed NCT03124446 - Mindfulness-Based College: Stage 1 N/A
Completed NCT03993652 - Kids FIRST: Family-based Intervention to Reduce Snacking and Screen Time in Children N/A
Completed NCT04766034 - Impact of Behavioral Economic Strategies on Low-Income Older Adults' Food Choices in Online Retail Settings N/A
Completed NCT03698123 - Performance Nutrition for Residents and Fellows N/A
Completed NCT03913871 - Text Message Program to Improve Eating Behaviors Among African Americans in New Orleans N/A
Completed NCT03941392 - Nutritional Study in Spanish Pediatric Population
Completed NCT03400566 - Effects of Experiential Learning on Vegetable Intake in Preschool Children N/A